Description
Gemtaz 1gm Injection 1’s gemtaz 1gm injections are potent antineoplastic agents, primarily used in the treatment of various types of cancer. These injections contain Gemtuzumab Ozogamicin, a recombinant humanized monoclonal antibody-drug conjugate, designed to target CD33-positive myeloid malignancies. The injections are administered intravenously and are known for their ability to induce apoptosis (programmed cell death) in cancer cells, thereby helping to manage the progression of cancer. Gemtaz Injections are a crucial component in comprehensive cancer care regimens, offering hope and improved outcomes for patients battling this disease.
Reviews
There are no reviews yet.